- Report
- January 2025
- 70 Pages
United States
From €5679EUR$5,950USD£4,758GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- January 2025
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- October 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 193 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- March 2025
- 194 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- August 2024
- 136 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- August 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- February 2025
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2025
- 191 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2025
- 210 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- January 2025
- 120 Pages
United States
From €2376EUR$2,490USD£1,991GBP
- Report
- February 2021
- 117 Pages
United States
From €4724EUR$4,950USD£3,958GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 138 Pages
South Korea
From €3435EUR$3,599USD£2,878GBP
- Report
- October 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP
- Report
- February 2024
- 85 Pages
North America
From €4533EUR$4,750USD£3,798GBP

Sevoflurane is an anesthetic drug used in medical procedures to induce and maintain general anesthesia. It is a volatile anesthetic, meaning it is administered as a gas and is rapidly eliminated from the body. It is a halogenated ether, meaning it contains a halogen atom, such as fluorine, bonded to an ether molecule. It is a colorless, non-flammable liquid with a pleasant odor. It is commonly used in pediatric and adult patients for induction and maintenance of general anesthesia. It is also used in combination with other anesthetic drugs to provide balanced anesthesia.
Sevoflurane is a popular anesthetic drug due to its rapid onset and offset of action, low blood solubility, and low risk of toxicity. It is also relatively inexpensive compared to other anesthetic drugs.
Some companies in the sevoflurane market include Baxter International, AbbVie, Merck & Co., and Hospira. Show Less Read more